カテゴリ： 世界, 医療/バイオ, Bizwit Research & Consulting

がん遺伝子治療のグローバル市場（2022年-2029年）：腫瘍溶解性ウイルス療法、遺伝子誘導疫療法、遺伝子導入

■ 英語タイトル：Global Cancer Gene Therapy Market Size study & Forecast, by Type (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), by End Use (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others) and Regional Analysis, 2022-2029

調査会社Bizwit Research & Consulting社が発行したリサーチレポート（データ管理コード：BZW23FE0109）■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23FE0109
■ 発行日：2023年1月29日
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医療
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥732,600見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥925,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[がん遺伝子治療のグローバル市場（2022年-2029年）：腫瘍溶解性ウイルス療法、遺伝子誘導疫療法、遺伝子導入]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Bizwit Research社の市場調査書によると、2021年に約16.8億ドルであった世界のがん遺伝子治療市場規模は、2022年から2029年の間に年平均19.99％拡大すると予測されています。当書は、がん遺伝子治療の世界市場を対象にし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、種類別（腫瘍溶解性ウイルス療法、遺伝子誘導疫療法、遺伝子導入）分析、エンドユーザー別（研究機関、バイオ製薬企業、診断センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどの項目について調査を行いました。なお、当書には、Abeona Therapeutics Inc.、Asklepios BioPharmaceutical Inc.、Bluebird bio Inc.、GlaxoSmithKlineInc.、Introgen TherapeuticsInc.、MerckKGaA、BioCancell Inc.、Elevate Bio Inc.、Genelux Corporationなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界がん遺伝子治療市場規模：種類別
- 腫瘍溶解性ウイルス療法の市場規模
- 遺伝子誘導疫療法の市場規模
- 遺伝子導入の市場規模
・世界がん遺伝子治療市場規模：エンドユーザー別
- 研究機関における市場規模
- バイオ製薬企業における市場規模
- 診断センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界のがん遺伝子治療市場規模：地域別
- 北米のがん遺伝子治療市場
- ヨーロッパのがん遺伝子治療市場
- アジア太平洋のがん遺伝子治療市場
- 中南米のがん遺伝子治療市場
- その他地域のがん遺伝子治療市場
・競争分析
・調査プロセス

Global Cancer Gene Therapy Market is valued at approximately USD 1.68 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 19.99% over the forecast period 2022-2029. Cancer gene therapy is a new treatment modality that assists in the introduction of new genes into a cancerous cell or the nearby tissue that leads to cell death or slows the growth of cancer. This treatment technique is flexible and a variety of genes and vectors are being utilized in clinical trials that present positive results, which is gaining huge popularity as a novel method for treating human ailments. The flourishing development of the pharmaceutical industry, surging demand for novel cancer therapeutics, and rising government support are the primary factors that are fostering market demand across the globe.

The rising incidences of cancer globally are a key driving factor for market growth. According to National Cancer Institute, in 2018, the number of cancer patients is estimated to account for 18.1 million, which is projected to reach 29.5 million patients by the year 2040. Accordingly, the growing prevalence of cancer is fueling the demand for wide range of diagnosis and treatment alternatives, which, in turn, accelerates the growth of the Cancer Gene Therapy Market. Moreover, the increasing technological advancements in cancer gene therapy, as well as growing R&D investments, are creating lucrative opportunities for market growth in the foreseen years. However, the high cost associated with gene therapy and unwanted immune responses is hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cancer Gene Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the presence of well-established market players and increasing investment in healthcare facilities in the region. Whereas, Europe is expected to grow at the highest CAGR during the forecast period. Factors such as rising research funding for novel therapeutics by government bodies, as well as growing demand for novel therapeutics are burgeoning the market growth in the forecasting years.

Major market players included in this report are:
Abeona Therapeutics Inc.
Asklepios BioPharmaceutical Inc.
Bluebird bio Inc.
GlaxoSmithKlineInc.
Introgen TherapeuticsInc.
MerckKGaA
BioCancell Inc.
Elevate Bio Inc.
Genelux Corporation
OncoGenex Pharmaceuticals Inc.
Recent Developments in the Market:
 In January 2022, Ori Biotech Ltd. publicized that the company has achieved above USD 100 million in funding in a Series B funding round, which is planned to use for the expansion of key personnel to support the launch of its innovative cell and gene therapy manufacturing platform.
 In June 2021, Eisai and Bristol Myers Squibb entered collaborative agreement to form and marketing of MORAb-202, Eisai’s ADC for advanced solid tumors.
Global Cancer Gene Therapy Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, End Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent to up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Oncolytic Virotherapy
Gene Induced Immunotherapy
Gene Transfer

By End Use:
Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

*** レポート目次（コンテンツ）***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Cancer Gene Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Cancer Gene Therapy Market, by Type, 2019-2029 (USD Billion)
1.2.3. Cancer Gene Therapy Market, by End Use, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Gene Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Gene Therapy Market Dynamics
3.1. Cancer Gene Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Surging demand for novel cancer therapeutics
3.1.1.2. Rising incidences of cancer globally
3.1.2. Market Challenges
3.1.2.1. High cost is associated with gene therapy
3.1.2.2. Unwanted immune responses
3.1.3. Market Opportunities
3.1.3.1. Increasing technological advancements in cancer gene therapy
3.1.3.2. Growing R&D investments
Chapter 4. Global Cancer Gene Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cancer Gene Therapy Market, by Type
6.1. Market Snapshot
6.2. Global Cancer Gene Therapy Market by Type, Performance – Potential Analysis
6.3. Global Cancer Gene Therapy Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Cancer Gene Therapy Market, Sub Segment Analysis
6.4.1. Oncolytic Virotherapy
6.4.2. Gene Induced Immunotherapy
6.4.3. Gene Transfer
Chapter 7. Global Cancer Gene Therapy Market, by End Use
7.1. Market Snapshot
7.2. Global Cancer Gene Therapy Market by End Use, Performance – Potential Analysis
7.3. Global Cancer Gene Therapy Market Estimates & Forecasts by End Use 2019-2029 (USD Billion)
7.4. Cancer Gene Therapy Market, Sub Segment Analysis
7.4.1. Research Institutes
7.4.2. Biopharmaceutical Companies
7.4.3. Diagnostic Centers
7.4.4. Others
Chapter 8. Global Cancer Gene Therapy Market, Regional Analysis
8.1. Cancer Gene Therapy Market, Regional Market Snapshot
8.2. North America Cancer Gene Therapy Market
8.2.1. U.S. Cancer Gene Therapy Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. End Use breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Cancer Gene Therapy Market
8.3. Europe Cancer Gene Therapy Market Snapshot
8.3.1. U.K. Cancer Gene Therapy Market
8.3.2. Germany Cancer Gene Therapy Market
8.3.3. France Cancer Gene Therapy Market
8.3.4. Spain Cancer Gene Therapy Market
8.3.5. Italy Cancer Gene Therapy Market
8.3.6. Rest of Europe Cancer Gene Therapy Market
8.4. Asia-Pacific Cancer Gene Therapy Market Snapshot
8.4.1. China Cancer Gene Therapy Market
8.4.2. India Cancer Gene Therapy Market
8.4.3. Japan Cancer Gene Therapy Market
8.4.4. Australia Cancer Gene Therapy Market
8.4.5. South Korea Cancer Gene Therapy Market
8.4.6. Rest of Asia Pacific Cancer Gene Therapy Market
8.5. Latin America Cancer Gene Therapy Market Snapshot
8.5.1. Brazil Cancer Gene Therapy Market
8.5.2. Mexico Cancer Gene Therapy Market
8.6. Rest of The World Cancer Gene Therapy Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abeona Therapeutics Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Asklepios BioPharmaceutical Inc.
9.2.3. Bluebird bio Inc.
9.2.4. GlaxoSmithKlineInc.
9.2.5. Introgen TherapeuticsInc.
9.2.6. MerckKGaA
9.2.7. BioCancell Inc.
9.2.8. Elevate BioInc.
9.2.9. Genelux Corporation
9.2.10. OncoGenex Pharmaceuticals Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Cancer Gene Therapy Market, report scope
TABLE 2. Global Cancer Gene Therapy Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Cancer Gene Therapy Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Cancer Gene Therapy Market estimates & forecasts by End Use 2019-2029 (USD Billion)
TABLE 5. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Cancer Gene Therapy Market
TABLE 70. List of primary sources, used in the study of global Cancer Gene Therapy Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 骨がん治療薬のグローバル市場（2022年-2029年）：骨肉腫、軟骨肉腫、ユーイング肉腫
  • 放射線治療装置のグローバル市場（2022年-2029年）：外部照射型放射線治療装置、内部照射型放射線治療装置、その他
  • バイオプロセス分析器のグローバル市場（2022年-2029年）：機器、消耗品
  • 肺炎検査のグローバル市場（2022年-2029年）：器具、試薬・消耗品
  • 結合型ワクチンのグローバル市場（2022年-2029年）：一価結合型ワクチン、多価結合型ワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BZW23FE0109 )"がん遺伝子治療のグローバル市場（2022年-2029年）：腫瘍溶解性ウイルス療法、遺伝子誘導疫療法、遺伝子導入" (英文：Global Cancer Gene Therapy Market Size study & Forecast, by Type (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), by End Use (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others) and Regional Analysis, 2022-2029)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。